US2008254127A1PendingUtilityA1
Inhalation particles incorporating a combination of two or more active ingredients
Est. expiryOct 6, 2020(expired)· nominal 20-yr term from priority
A61P 37/00A61P 43/00A61P 5/00A61P 9/06A61P 35/00A61P 31/10A61P 3/10A61P 29/00A61P 3/02A61P 31/12A61P 25/20A61P 25/18A61K 31/57A61K 9/0075A61P 11/00A61K 45/06A61K 31/167A61K 31/165A61P 11/10A61K 31/573A61P 11/06A61P 11/08
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Crystalline spherical inhalation particles incorporating a combination of two or more different active ingredients and a process for the preparation thereof. The particles have a narrow particle size distribution, rough surfaces and improved stability. The inhalation particles of the invention are particularly useful in the administration of a combination medicament, e.g. a combination of an anti-inflammatory agent and a bronchodilator, by inhalation in the treatment of asthma and other respiratory disorders.
Claims
exact text as granted — not AI-modified1 - 21 . (canceled)
22 . Inhalation particles incorporating, in an unagglomerated individual particle, a combination of two or more different active ingredients, wherein said particles are spherical and at least one of the active ingredients is in crystalline form.
23 . Inhalation particles according to claim 22 , wherein the mean mass aerodynamic diameter of said particles is about 1-5 μm.
24 . Inhalation particles according to claim 22 , wherein the aerodynamic particle size distribution of said particles is about 0.5-10 μm.
25 . Inhalation particles according to claim 22 , wherein the ratio of the active ingredients is constant.
26 . Inhalation particles according to claim 22 , wherein the particles have a rough surface.
27 . Inhalation particles according to claim 22 , wherein the particles are uncharged.
28 . Inhalation particles according to claim 22 , incorporating a combination of beclomethasone dipropionate and formoterol fumarate.
29 . An inhalation composition comprising particles incorporating, in an unagglomerated individual particle, a combination of two or more different active ingredients, wherein said particles are spherical and at least one of the active ingredients is in crystalline form.
30 . An inhalation composition according to claim 29 additionally comprising one or more pharmaceutically acceptable additives, diluents or carriers.
31 . An inhalation composition according to claim 29 in the form of dry inhalation powder.
32 . An inhalation composition according to claim 29 in the form of pressurized metered dose inhalation suspension.
33 . An inhaler device comprising an inhalation composition according to claim 29 .
34 . A method for preparing particles incorporating, in an unagglomerated individual particle, a combination of two or more different active ingredients comprising the steps of:
providing liquid feed stock comprising two or more different active ingredients in a predetermined ratio: atomising said liquid feed stock to create droplets: suspending said droplets in a carrier gas; passing said carrier gas and droplets suspended therein through a heated tube flow reactor under predetermined residence time and temperature history; and collecting the particles produced.
35 . A method of claim 34 wherein the liquid feed stock, comprising two or more different active ingredients in a predetermined ratio, is in the form of a solution.
36 . A method according to claim 34 , wherein the carrier gas is selected from nitrogen gas or other inert gas.
37 . A method according to claim 34 , wherein the particles are collected using a particle collection system selected from an electrostatic precipitator, a cyclone or a filter.
38 . A method according to claim 37 , wherein the particle collection system is heated to a temperature above the boiling point temperature of the solution to prevent condensation.
39 . A method according to claim 34 , wherein the liquid feedstock comprises beclomethasone dipropionate and formoterol fumarate as active ingredients.
40 . A method according to claim 39 , wherein the liquid feed stock comprises ethanol as a solvent.
41 . Inhalation particles according to claim 22 , wherein the aerodynamic particle size distribution of said particles is about 1-5 μm.Join the waitlist — get patent alerts
Track US2008254127A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.